FIELD: medicine.
SUBSTANCE: invention describes a method for typing in vitro an inflammatory rheumatic disease, namely for differentiating rheumatoid arthritis and arthritis related to skin disease, wherein the presence or absence of joint fluid Hdj2 protein at the early stage of the disease, i.e. for a period of time up to two years from the onset of first symptoms of inflammatory rheumatoid arthritis, is determined. What is also described is using Hdj2 protein monoclonal antibodies for the purpose of differential diagnosis in vitro of the inflammatory rheumatic disease.
EFFECT: invention enables the early diagnosis of rheumatoid arthritis.
5 cl, 4 ex, 3 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR EARLY STAGE OF RHEUMATOID ARTHRITIS | 2013 |
|
RU2524616C1 |
C1 PROTEIN 2 CHAIN OF CARTILAGE INTERMEDIATE LAYER AND USE THEREOF FOR DIFFERENTIAL DIAGNOSIS OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS AND NON-PATHOLOGICAL STATES | 2008 |
|
RU2481586C2 |
DIAGNOSTIC TECHNIQUE FOR RHEUMATOID ARTHRITIS IF MUTATED CITRULLINATED VIMENTIN ANTIBODIES (Anti-MCV) ARE FOUND IN ORAL FLUID | 2012 |
|
RU2523413C1 |
NOVEL METHOD OF DIAGNOSING RHEUMATOID ARTHRITIS AND SET FOR RHEUMATOID ARTHRITIS DIAGNOSTICS | 2011 |
|
RU2554751C2 |
TREATMENT OF PROLIFERATIVE ARTHRITIS | 2003 |
|
RU2322238C2 |
DIAGNOSTIC TECHNIQUE FOR INFLAMMATORY PROCESS IN EARLY RHEUMATOID ARTHRITIS | 2009 |
|
RU2417263C2 |
METHOD FOR EARLY DIAGNOSIS OF RHEUMATOID ARTHRITIS | 2019 |
|
RU2735738C1 |
PEPTOID LIGANDS FOR AUTOIMMUNE T-CELL RECOVERY AND PROCESSING | 2010 |
|
RU2563822C2 |
METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R) | 2012 |
|
RU2670743C9 |
TREATING AND DIAGNOSING MACROPHAGUE-MEDIATED DISEASES | 2007 |
|
RU2480241C2 |
Authors
Dates
2014-01-20—Published
2009-03-05—Filed